Natraj Proteins

Which are the latest news on Natraj Proteins?

Should I buy, sell or hold Natraj Proteins Ltd?

Why is Natraj Proteins Ltd falling/rising?

As of 07-Jul, Natraj Proteins Ltd's stock price is declining, currently at 35.35, down 4.46%. The stock has underperformed the sector and benchmark indices, with significant negative returns over various time frames and waning investor participation.

As of 07-Jul, Natraj Proteins Ltd's stock price is falling, currently at 35.35, which reflects a decrease of 1.65 or 4.46%. This decline is part of a broader trend, as the stock has underperformed the sector by 0.81% today and has experienced consecutive falls over the last two days, totaling a drop of 7.65% in that period. <BR><BR>In terms of performance metrics, the stock has shown negative returns over various time frames, including a 1-week decline of 7.44% and a 1-year decrease of 14.82%. Additionally, the stock's performance is significantly lagging behind the benchmark Sensex, which has gained 2.23% in the past week and 5.30% over the last month. <BR><BR>Investor participation appears to be waning, as evidenced by a 31.22% drop in delivery volume compared to the 5-day average. Although the stock is trading above its 100-day and 200-day moving averages, it is below its 5-day, 20-day, and 50-day moving averages, indicating a potential short-term weakness. Overall, these factors contribute to the current downward trend in Natraj Proteins Ltd's stock price.

How big is Natraj Proteins?

As of 10th June, Natraj Proteins Ltd has a market capitalization of 14.00 Cr, with recent net sales of 101.12 Cr and a net profit of 1.14 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Natraj Proteins Ltd has a market capitalization of 14.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 101.12 Cr, while the sum of Net Profit for the same period is 1.14 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 32.23 Cr, and Total Assets amount to 58.63 Cr.

Who are in the management team of Natraj Proteins?

The management team of Natraj Proteins includes Kailash Chand Sharma (Chairman & Managing Director), Sharad Kumar Jain (Whole-time Director), Umesh Trivedi, Pradeep Agrawal, and Rajendra Singh Tomar (Independent Directors), Namita Sharma (Director), and Pooja Agrawal (Company Secretary & Compliance Officer).

The management team of Natraj Proteins includes the following individuals:<BR><BR>1. **Kailash Chand Sharma** - Chairman & Managing Director<BR>2. **Sharad Kumar Jain** - Whole-time Director<BR>3. **Umesh Trivedi** - Independent Director<BR>4. **Pradeep Agrawal** - Independent Director<BR>5. **Namita Sharma** - Director<BR>6. **Rajendra Singh Tomar** - Independent Director<BR>7. **Pooja Agrawal** - Company Secretary & Compliance Officer<BR><BR>If you need more specific information about their roles or responsibilities, feel free to ask!

Who are the peers of the Natraj Proteins?

Natraj Proteins' peers include Poona Dal & Oil, Ambo Agritec, Vandan Foods, and others. In terms of management risk, growth, and capital structure, Natraj shows average performance, with a 1-year return of -9.07%, better than Ambo Agritec's -81.79% but worse than Signature Green's 45.79%.

Peers: The peers of Natraj Proteins are Poona Dal & Oil, Ambo Agritec, Vandan Foods, Madhusudan Inds., Prima Industries, Ashiana Agro Ind, Signature Green, and N K Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at Vandan Foods, while Average management risk is found at Madhusudan Inds. and Natraj Proteins, and Below Average management risk is noted at Poona Dal & Oil, Ambo Agritec, Prima Industries, and the rest. For Growth, Good growth is seen at Ambo Agritec, Average growth at Vandan Foods, and Below Average growth at Natraj Proteins, Madhusudan Inds., Poona Dal & Oil, Prima Industries, and the rest. In terms of Capital Structure, Good capital structure is present at Vandan Foods and Below Average capital structure is noted at Natraj Proteins, Madhusudan Inds., Poona Dal & Oil, Ambo Agritec, Prima Industries, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Signature Green at 45.79%, while Ambo Agritec has the lowest at -81.79%. Natraj Proteins' 1-year return is -9.07%, which is better than Ambo Agritec but worse than Signature Green. Additionally, the six-month return is negative for Ambo Agritec, Madhusudan Inds., Prima Industries, N K Industries, and the rest.

What does Natraj Proteins do?

Natraj Proteins Ltd is a micro-cap company in the edible oil industry, manufacturing crude oil, refined oil, and de-oiled cake. As of March 2026, it reported net sales of 19 Cr and a net profit of 1 Cr, with a market cap of INR 14 Cr.

Overview:<BR>Natraj Proteins Ltd is a micro-cap company in the edible oil industry that manufactures crude oil, edible grade refined oil, and de-oiled cake.<BR><BR>History:<BR>Incorporated in November 1990, Natraj Proteins Ltd has been operational since its establishment. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 19 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 1 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 14 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 13.00 <BR>Industry P/E: 22 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.69 <BR>Return on Equity: 3.89% <BR>Price to Book: 0.49 <BR><BR>Contact Details:<BR>Address: Nagpur Kalan, Ordinance Factory Road Itarsi Madhya Pradesh : 461111 <BR>Tel: 91-07572-262636 <BR>Email: natrajproteins@rediffmail.com <BR>Website: http://www.natralproteins.com

Are Natraj Proteins Ltd latest results good or bad?

Natraj Proteins Ltd's latest results show a return to profitability with a net profit of ₹1.11 crores in Q4 FY26, a 244.2% improvement from previous quarters. However, a significant 34.41% decline in revenue and shrinking margins indicate ongoing challenges, suggesting a cautious outlook for investors.

Natraj Proteins Ltd's latest results present a mixed picture. On one hand, the company has returned to profitability in Q4 FY26, reporting a net profit of ₹1.11 crores, which is a significant improvement of 244.2% compared to the average of the previous four quarters. This indicates some operational resilience after two consecutive quarters of losses.<BR><BR>However, the revenue figures are concerning. The company experienced a sharp decline in revenue, with net sales falling by 34.41% quarter-on-quarter to ₹18.87 crores, marking the lowest quarterly revenue in recent history. This decline is compounded by an 18.17% year-on-year decrease, suggesting ongoing challenges in maintaining sales levels.<BR><BR>Additionally, operating margins and profit margins have also contracted, with operating margins dropping to 9.06% and PAT margins to 5.88%, both reflecting a decrease from previous quarters. The volatility in both revenue and profitability raises questions about the sustainability of the recent profitability recovery.<BR><BR>Overall, while the return to profit is a positive sign, the significant drop in revenue and ongoing operational challenges indicate that the results are not entirely favorable. Investors should approach with caution, considering the structural issues that may affect future performance.

When is the next results date for Natraj Proteins Ltd?

The next results date for Natraj Proteins Ltd is 22 May 2026.

The next results date for Natraj Proteins Ltd is scheduled for 22 May 2026.

Is Natraj Proteins overvalued or undervalued?

As of November 17, 2025, Natraj Proteins is considered undervalued with a valuation grade shift to attractive, featuring a PE ratio of -9.07 and an EV to EBITDA of 34.42, significantly lower than peers like Gokul Agro and Guj. Ambuja Exp, despite a year-to-date return of -14.80% compared to the Sensex's 8.72%, indicating potential for recovery and growth.

As of 17 November 2025, the valuation grade for Natraj Proteins has moved from expensive to attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of -9.07, an EV to EBITDA of 34.42, and a Price to Book Value of 0.49, which highlight its low valuation compared to earnings and assets.<BR><BR>In comparison to peers, Gokul Agro has a PE ratio of 20.15 and an EV to EBITDA of 10.23, while Guj. Ambuja Exp shows a PE of 22.97 and an EV to EBITDA of 11.75, both of which are considerably higher than Natraj Proteins. This suggests that Natraj is trading at a discount relative to its peers in the edible oil industry. Despite recent underperformance against the Sensex, with a year-to-date return of -14.80% compared to the Sensex's 8.72%, the attractive valuation suggests potential for recovery and growth.

How has been the historical performance of Natraj Proteins?

Natraj Proteins has experienced significant fluctuations in financial performance, with declining net sales and operating income, but improved cash flow from operations. Despite a positive operating profit in Mar'25, the company continues to face challenges with negative profits before and after tax.

Answer:<BR>The historical performance of Natraj Proteins shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Natraj Proteins experienced a decline in net sales from 193.73 Cr in Mar'24 to 117.78 Cr in Mar'25, following a trend of decreasing sales since Mar'23 when it was 143.60 Cr. The total operating income mirrored this decline, dropping to 117.78 Cr in Mar'25 from 193.73 Cr in Mar'24. Raw material costs also decreased significantly, falling from 150.82 Cr in Mar'24 to 95.70 Cr in Mar'25. Despite this reduction in costs, the operating profit (PBDIT) turned positive at 1.61 Cr in Mar'25 after being negative in Mar'24. However, the company reported a profit before tax of -1.18 Cr in Mar'25, indicating ongoing challenges. The profit after tax also remained negative at -1.46 Cr. The total liabilities decreased from 77.83 Cr in Mar'24 to 58.63 Cr in Mar'25, while total assets also fell from 77.83 Cr to 58.63 Cr in the same period. Cash flow from operating activities showed improvement, reaching 21.00 Cr in Mar'25 compared to -5.00 Cr in Mar'24, but the net cash inflow/outflow remained at 0.00 Cr in Mar'25. Overall, Natraj Proteins has faced significant challenges in profitability and sales, while managing to improve cash flow from operations.

What is the technical trend for Natraj Proteins?

As of May 12, 2025, Natraj Proteins shows a mildly bearish trend with mixed signals: the weekly MACD is mildly bullish, the monthly MACD is bearish, and while the RSI is bullish on the monthly chart, Bollinger Bands and moving averages indicate bearishness across both daily and monthly charts.

As of 12 May 2025, the technical trend for Natraj Proteins has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish, suggesting mixed signals across time frames. The RSI shows no signal on the weekly chart but is bullish on the monthly, indicating potential strength in longer-term momentum. However, Bollinger Bands and moving averages are bearish on both daily and monthly charts, reinforcing the overall bearish sentiment. The KST is mildly bullish weekly but bearish monthly, further contributing to the mixed outlook. Overall, the current stance is mildly bearish, with key indicators showing divergence between short-term and long-term trends.

Who are the top shareholders of the Natraj Proteins?

The top shareholders of Natraj Proteins include promoter Sharad Kumar Jain with 6.38% and public shareholder Sangeetha S with 5.75%. Individual investors hold 50.62% of shares, with no pledged promoter holdings and minimal institutional involvement.

The top shareholders of Natraj Proteins include Sharad Kumar Jain, who is the promoter with the highest holding at 6.38%. The highest public shareholder is Sangeetha S, holding 5.75%. Additionally, individual investors collectively hold 50.62% of the company's shares. There are no pledged promoter holdings, and the company has minimal institutional involvement, with only one mutual fund scheme holding 1.9% and no foreign institutional investors.

Has Natraj Proteins declared dividend?

No Dividend History Available